Form 4: Cognition Therapeutics CFO John Brendan Doyle Reports Tax Withholding Transaction
SEC Form 4 Filing
John Brendan Doyle, CFO of Cognition Therapeutics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On May 1, 2024, John Brendan Doyle, the Chief Financial Officer of Cognition Therapeutics Inc. (CGTX), had 8,699 shares of common stock withheld by the issuer to cover tax withholding obligations.
- The shares were withheld in connection with the vesting of restricted stock units at a price of $1.95.
- Following the transaction, Doyle directly owns 121,125 shares of Cognition Therapeutics Inc.
Sentiment
Score: 5
Explanation: This is a neutral report on a routine transaction related to executive compensation. It doesn't indicate positive or negative sentiment.
Industry Context
This is a routine filing related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of transaction: Shares withheld for tax obligations. |
| 05/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.